Search Results - "BILZ, Stefan"

Refine Results
  1. 1
  2. 2
  3. 3

    Diagnostic precision and identification of rare diseases is dependent on distance of residence relative to tertiary medical facilities by Walter, Anna-Lena, Baty, Florent, Rassouli, Frank, Bilz, Stefan, Brutsche, Martin Hugo

    Published in Orphanet journal of rare diseases (22-03-2021)
    “…Diagnostic precision and the identification of rare diseases is a daily challenge, which needs specialized expertise. We hypothesized, that there is a…”
    Get full text
    Journal Article
  4. 4

    Diabetic kidney disease in type 2 diabetes: a consensus statement from the Swiss Societies of Diabetes and Nephrology by Zanchi, Anne, Jehle, Andreas W, Lamine, Faiza, Vogt, Bruno, Czerlau, Cecilia, Bilz, Stefan, Seeger, Harald, de Seigneux, Sophie

    Published in Swiss medical weekly (06-01-2023)
    “…Diabetic kidney disease is highly prevalent in patients with type 2 diabetes and is a major cause of end-stage renal disease in Switzerland. Patients with…”
    Get full text
    Journal Article
  5. 5

    Mechanism of Hepatic Insulin Resistance in Non-alcoholic Fatty Liver Disease by Samuel, Varman T, Liu, Zhen-Xiang, Qu, Xianqin, Elder, Benjamin D, Bilz, Stefan, Befroy, Douglas, Romanelli, Anthony J, Shulman, Gerald I

    Published in The Journal of biological chemistry (30-07-2004)
    “…Short term high fat feeding in rats results specifically in hepatic fat accumulation and provides a model of non-alcoholic fatty liver disease in which to…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Neuroendocrine regulation and metabolism of glucose and lipids in primary chronic insomnia: a prospective case-control study by Seelig, Eleonora, Keller, Ulrich, Klarhöfer, Markus, Scheffler, Klaus, Brand, Serge, Holsboer-Trachsler, Edith, Hatzinger, Martin, Bilz, Stefan

    Published in PloS one (12-04-2013)
    “…To investigate the relation between primary chronic insomnia and insulin sensitivity, visceral adiposity, non alcoholic fatty liver disease and neuroendocrine…”
    Get full text
    Journal Article
  9. 9

    Comparison of the dose-response pharmacodynamic profiles of detemir and glargine in severely obese patients with type 2 diabetes: A single-blind, randomised cross-over trial by Bilz, Stefan, Flückiger, Miriam, Meienberg, Fabian, Falconnier, Claudine, Keller, Ulrich, Puder, Jardena J

    Published in PloS one (16-08-2018)
    “…Despite their widespread use in this population, data on the pharmacodynamic (PD) properties of the insulin analogs detemir and glargine in severely obese…”
    Get full text
    Journal Article
  10. 10

    Controlling glycemic variability in people living with type 1 diabetes receiving insulin glargine 300 U/mL (Gla-300) by Mader, Julia K, Gölz, Stefan, Bilz, Stefan, Bramlage, Peter, Danne, Thomas

    Published in BMJ open diabetes research & care (01-08-2022)
    “…Short-term glycemic variability is associated with the risk of hypoglycemia and hyperglycemia in people living with type 1 diabetes and can potentially affect…”
    Get full text
    Journal Article
  11. 11

    Catecholamine metabolism in paraganglioma and pheochromocytoma: similar tumors in different sites? by Grouzmann, Eric, Tschopp, Oliver, Triponez, Frédéric, Matter, Maurice, Bilz, Stefan, Brändle, Michael, Drechser, Tilman, Sigrist, Sarah, Zulewski, Henryk, Henzen, Christoph, Fischli, Stefan, Abid, Karim

    Published in PloS one (06-05-2015)
    “…Pheochromocytoma (PHEO) and paraganglioma (PGL) are catecholamine-producing neuroendocrine tumors that arise respectively inside or outside the adrenal…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Concentrations of the stress hormone copeptin increase upon hypoglycaemia in patients with type 1 diabetes dependent of hypoglycaemia awareness by Seelig, Eleonora, Bilz, Stefan, Keller, Ulrich, Meienberg, Fabian, Christ-Crain, Mirjam

    Published in PloS one (30-08-2013)
    “…Copeptin, a marker for stress mirroring vasopressin concentrations, has been shown to increase upon insulin-induced hypoglycaemia in patients after…”
    Get full text
    Journal Article
  14. 14

    Muscle-Specific IRS-1 Ser→Ala Transgenic Mice Are Protected From Fat-Induced Insulin Resistance in Skeletal Muscle by MORINO, Katsutaro, NESCHEN, Susanne, WHITE, Morris, PHILBRICK, William, SHULMAN, Gerald I, BILZ, Stefan, SONO, Saki, TSIRIGOTIS, Dimitrios, REZNICK, Richard M, MOORE, Irene, NAGAI, Yoshio, SAMUEL, Varman, SEBASTIAN, David

    Published in Diabetes (New York, N.Y.) (01-10-2008)
    “…Muscle-Specific IRS-1 Ser→Ala Transgenic Mice Are Protected From Fat-Induced Insulin Resistance in Skeletal Muscle Katsutaro Morino 1 2 , Susanne Neschen 1 2 ,…”
    Get full text
    Journal Article
  15. 15

    Monoamine Oxidase A Down-Regulation Contributes to High Metanephrine Concentration in Pheochromocytoma by Grouzmann, Eric, Matter, Maurice, Bilz, Stefan, Herren, Adeline, Triponez, Frédéric, Henzen, Christophe, Kim, Kwang-Soo, Zulewski, Henryk, Buclin, Thierry, Brakch, Noureddine, Abid, Karim

    “…Context: The high diagnostic performance of plasma-free metanephrines (metanephrine and normetanephrine) (MN) for pheochromocytoma (PHEO) results from the…”
    Get full text
    Journal Article
  16. 16

    Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamsters by Bilz, Stefan, Samuel, Varman, Morino, Katsutaro, Savage, David, Choi, Cheol Soo, Shulman, Gerald I

    “…The transcription factor farnesoid X receptor (FXR) has recently been implicated in the control of hepatic triglyceride production. Activation of FXR may…”
    Get more information
    Journal Article
  17. 17

    Effects of atorvastatin versus fenofibrate on apoB-100 and apoA-I kinetics in mixed hyperlipidemia by Bilz, Stefan, Wagner, Stephan, Schmitz, Michaela, Bedynek, Andrea, Keller, Ulrich, Demant, Thomas

    Published in Journal of lipid research (01-01-2004)
    “…Kinetics of apo B and apo AI were assessed in 8 patients with mixed hyperlipidemia at baseline and after 8 weeks of atorvastatin 80 mg q.d. and micronised…”
    Get full text
    Journal Article
  18. 18

    A rare case of an ACTH/CRH co-secreting midgut neuroendocrine tumor mimicking Cushing's disease by Streuli, Regina, Krull, Ina, Brändle, Michael, Kolb, Walter, Stalla, Günter, Theodoropoulou, Marily, Enzler-Tschudy, Annette, Bilz, Stefan

    “…Summary Ectopic ACTH/CRH co-secreting tumors are a very rare cause of Cushing’s syndrome and only a few cases have been reported in the literature…”
    Get full text
    Journal Article
  19. 19
  20. 20